Alkermes plc buy melinda
Start price
18.10.17
/
50%
€46.34
Target price
27.10.17
€49.61
Performance (%)
7.49%
End price
27.10.17
€49.82
Summary
This prediction ended on 27.10.17 with a price of €49.82. The BUY prediction by melinda finished with a performance of 7.49%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alkermes plc | 0.704% | 0.704% | 17.213% | 12.598% |
| iShares Core DAX® | -0,37 % | 8,40 % | 6,76 % | 47,91 % |
| iShares Nasdaq 100 | 2,27 % | 15,23 % | 36,18 % | 94,08 % |
| iShares Nikkei 225® | 1,43 % | 14,42 % | 43,11 % | 64,80 % |
| iShares S&P 500 | 1,22 % | 10,49 % | 27,28 % | 66,76 % |
Comments by melinda for this prediction
In the thread Alkermes plc diskutieren
Biotechnologie und medizinische SecteurRecherche
Neue Studie zur Bewertung der Wirksamkeit von extended-release Naltrexon mit Buprenorphin-Naloxon für Opiatabhängigkeit Veröffentlicht in JAMA Psychiatrie Vergleich